Published in
BioMed Central, BMC Cancer, 1(16), 2016
DOI: 10.1186/s12885-016-2124-5
Links
- ORCID
- BioMed Central
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [curis.ku.dk] | PDF
Tools
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification
Journal article published in 2016 by
Line S. Tarpgaard,
Camilla Qvortrup 
,
Sune B. Nygård,
Signe L. Nielsen,
Diana R. Andersen,
Niels Frank Jensen,
Jan Stenvang,
Sönke Detlefsen,
Nils Brünner,
Per Pfeiffer
,
Sune B. Nygård,
Signe L. Nielsen,
Diana R. Andersen,
Niels Frank Jensen,
Jan Stenvang,
Sönke Detlefsen,
Nils Brünner,
Per Pfeiffer
This paper is made freely available by the publisher.
Full text: Download
Data provided by 